iNova Pharmaceutical's acquisition of Juno PC JV raises Australian competition concerns
MLex Summary: iNova Pharmaceutical (Australia)'s plans to buy pharmaceutical joint venture Juno PC have suffered a regulatory setback after Australia's competition regulator announced today that the deal raises competition concerns. In...To view the full article, register now.
Already a subscriber? Click here to view full article